Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
18 pending office actions • 12 art units • 16 examiners • 0 of 18 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Nutricia operates a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 19 pending office actions. These actions are spread across 17 distinct examiners and 11 distinct art units. This distribution of 19 actions across 11 distinct art units suggests that the company's applications are being reviewed by several different specialized groups. For a practitioner, the 19 pending office actions require interaction with 17 distinct examiners, meaning that the company must adapt to many different examination styles within the Biotechnology & Pharmaceuticals sector.
The busiest examiner for the company is YOO, HONG THI, who is handling 2 busiest examiner pending office actions. Given the total of 19 pending office actions, the workload is distributed among the 17 distinct examiners, with the busiest examiner managing only 2 of the company's active matters. This count of 2 actions per busiest examiner is low relative to the 19 total pending office actions, indicating that the prosecution is not concentrated under any single individual across the 11 distinct art units.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (6%) |
| §103 only | 8 (44%) |
| Double-patenting only | 1 (6%) |
| Double-patenting + other | 1 (6%) |
| Multi-statute (no §101) | 7 (39%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YOO, HONG THI | 2 | 46.0% | +25.3% |
| CRUM, MARY ABOU NADER | 2 | 39.2% | +63.7% |
| ORTIZ, RAFAEL ALFREDO | 1 | 61.3% | +35.1% |
| BOECKELMAN, JACOB A | 1 | 34.9% | +46.5% |
| MUKHOPADHYAY, BHASKAR | 1 | 28.2% | +37.0% |
| WILSON, JERICA KATLYNN | 1 | 60.5% | +39.8% |
| KELLEY, CHRISTOPHER S | 1 | 32.0% | +8.9% |
| MI, QIUWEN | 1 | 68.4% | +50.0% |
| LIU, DEBORAH YANG-HAO | 1 | 8.9% | +12.3% |
| SCHACHERMEYER, SAMANTHA LYNN | 1 | 35.7% | +70.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17289249 | Nutritional composition comprising urea and non-digestible oligosaccharides | KIM, BRYAN | 27d |
| 19171508 | Card Based Lid with Scoop Holder and Scoop | ORTIZ, RAFAEL ALFREDO | — |
| 18817331 | Fatty acids for boostering ketogenic diet | MUKHOPADHYAY, BHASKAR | — |
| 18815872 | Fatty acids for ketosis control | WILSON, JERICA KATLYNN | — |
| 18741853 | Mix of specific Bifidobacterium species and specific non-digestible oligosaccharides | YOO, HONG THI | — |
| 18602064 | Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases | MI, QIUWEN | — |
| 18564620 | Lactation stage specific infant nutrition | LIU, DEBORAH YANG-HAO | — |
| 17775890 | INFANT FORMULA WITH SPECIAL LIPID ARCHITECTURE FOR IMPROVING POSTNATAL GROWTH OF INFANTS BORN TO OVERWEIGHT AND OBESE MOTHERS | MERRIAM, ANDREW E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17283287 | NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE | CRUM, MARY ABOU NADER | 4d overdue |
| 18557304 | Galactooligosaccharides for improving immune response | SCHACHERMEYER, SAMANTHA LYNN | 13d |
| 17283265 | Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection | CRUM, MARY ABOU NADER | 62d |
| 19171508 | Card Based Lid with Scoop Holder and Scoop | ORTIZ, RAFAEL ALFREDO | — |
| 18882804 | Nutritional composition for cancer | BOECKELMAN, JACOB A | — |
| 18817331 | Fatty acids for boostering ketogenic diet | MUKHOPADHYAY, BHASKAR | — |
| 18815872 | Fatty acids for ketosis control | WILSON, JERICA KATLYNN | — |
| 18741853 | Mix of specific Bifidobacterium species and specific non-digestible oligosaccharides | YOO, HONG THI | — |
| Art Unit | Apps |
|---|---|
| 1792 | 4 |
| 1655 | 2 |
| 1791 | 2 |
| 1657 | 2 |
| 3736 | 1 |
| 1621 | 1 |
| 2482 | 1 |
| 1693 | 1 |
| 1654 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19171508 | Card Based Lid with Scoop Holder and Scoop | ORTIZ, RAFAEL ALFREDO | 3736 | §103§112 | Non-Final OA | — | Pending | Apr 07, 2025 |
| 18882804 | Nutritional composition for cancer | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18817331 | Fatty acids for boostering ketogenic diet | MUKHOPADHYAY, BHASKAR | 1792 | §103§112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18815872 | Fatty acids for ketosis control | WILSON, JERICA KATLYNN | 1621 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18741853 | Mix of specific Bifidobacterium species and specific non-digestible oligosaccharides | YOO, HONG THI | 1792 | §103§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18607598 | ELECTRONIC DEVICE AND METHOD FOR DETERMINING HUMAN HEIGHT USING NEURAL NETWORKS | KELLEY, CHRISTOPHER S | 2482 | §103 | Final Rejection | 28d overdue | Pending | Mar 18, 2024 |
| 18602064 | Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases | MI, QIUWEN | 1655 | §103§112 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18564620 | Lactation stage specific infant nutrition | LIU, DEBORAH YANG-HAO | 1791 | §103 | Final Rejection | — | Pending | Nov 28, 2023 |
| 18557304 | Galactooligosaccharides for improving immune response | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Final Rejection | 13d | Pending | Oct 26, 2023 |
| 18549938 | LIQUID NUTRITIONAL COMPOSITION SUITABLE FOR MUSCLE FUNCTION | BOWLES, DAVID PAUL | 1654 | §103 | Non-Final OA | 5d | Pending | Sep 11, 2023 |
| 18256057 | FIBRE MIXTURE FOR YOUNG CHILDREN | CREWS, JARET JAMES | 1691 | §103 | Non-Final OA | 16d | Pending | Jun 06, 2023 |
| 17775890 | INFANT FORMULA WITH SPECIAL LIPID ARCHITECTURE FOR IMPROVING POSTNATAL GROWTH OF INFANTS BORN TO OVERWEIGHT AND OBESE MOTHERS | MERRIAM, ANDREW E | 1791 | §103§112 | Final Rejection | — | Pending | May 11, 2022 |
| 17611197 | Composition comprising vitamin A and non digestible oligosaccharides | YOO, HONG THI | 1792 | §103§112 | Final Rejection | — | Pending | Nov 15, 2021 |
| 17289249 | Nutritional composition comprising urea and non-digestible oligosaccharides | KIM, BRYAN | 1792 | §103§112 | Non-Final OA | 27d | Pending | Apr 28, 2021 |
| 17283287 | NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE | CRUM, MARY ABOU NADER | 1657 | DP | Non-Final OA | 4d overdue | Pending | Apr 07, 2021 |
| 17283265 | Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection | CRUM, MARY ABOU NADER | 1657 | §103DP | Final Rejection | 62d | Pending | Apr 07, 2021 |
| 17270928 | Thickened composition for dysphagia patients | GWARTNEY, ELIZABETH A | 1759 | §103 | Final Rejection | 30d overdue | Pending | Feb 24, 2021 |
| 16339874 | Normalization of the Intestinal Microbiota Composition in Infants or Toddlers Fed with an Amino Acid-Based Nutritional Composition | FERNANDEZ, SUSAN EMILY | 1651 | §103 | Final Rejection | 3d overdue | Pending | Apr 05, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNutricia has 18 pending office actions as of October 2026, spread across 12 art units and 16 examiners.
Hong Thi Yoo has the most, with 2 of Nutricia's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
